» Articles » PMID: 32813154

Polypharmacy, Benzodiazepines, and Antidepressants, but Not Antipsychotics, Are Associated with Increased Falls Risk in UK Care Home Residents: a Prospective Multi-centre Study

Overview
Journal Eur Geriatr Med
Specialty Geriatrics
Date 2020 Aug 20
PMID 32813154
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Falls and polypharmacy are both common in care home residents. Deprescribing of medications in residents with increased falls risk is encouraged. Psychotropic medications are known to increase falls risk in older adults. These drugs are often used in care home residents for depression, anxiety, and behavioural and psychological symptoms of dementia. However, a few studies have explored the link between polypharmacy, psychotropic medications, and falls risk in care home residents.

Methods: This was a prospective cohort study of residents from 84 UK care homes. Data were collected from residents' care records and medication administration records. Age, diagnoses, gender, number of medications, and number of psychotropic medications were collected at baseline and residents were monitored over three months for occurrence of falls. Logistic regression models were used to assess the effect of multiple medications and psychotropic medication on falls whilst adjusting for confounders.

Results: Of the 1655 participants, mean age 85 (SD 8.9) years, 67.9% female, 519 (31%) fell in 3 months. Both the total number of regular drugs prescribed and taking ≥ 1 regular psychotropic medication were independent risk factors for falling (adjusted odds ratio (OR) 1.06 (95% CI 1.03-1.09, p < 0.01) and 1.39 (95% CI 1.10-1.76, p < 0.01), respectively). The risk of falls was higher in those taking antidepressants (p < 0.01) and benzodiazepines (p < 0.01) but not antipsychotics (p > 0.05).

Conclusion: In UK care homes, number of medications and psychotropic medications (particularly antidepressants and benzodiazepines) predicted falls. This information can be used to inform prescribing and deprescribing decisions.

Citing Articles

Neuropsychiatric Symptoms and Psychotropic Medication Use Following SARS-Cov-2 Infection Among Elderly Residents in Long-Term Care Facilities.

Cruz-Santiago D, Meng X, Canac-Marquis M, Sengupta A, Brassard J, Pavey E Can Geriatr J. 2025; 28(1):67-72.

PMID: 40051588 PMC: 11882206. DOI: 10.5770/cgj.28.770.


Understanding polypharmacy for people receiving home care services: a scoping review of the evidence.

Karimi R, Robinson-Barella A, Davey V, Sinclair D, Hanratty B, Todd A Age Ageing. 2025; 54(2).

PMID: 39970067 PMC: 11837856. DOI: 10.1093/ageing/afaf031.


Influence of Ageing on the Pharmacodynamics and Pharmacokinetics of Chronically Administered Medicines in Geriatric Patients: A Review.

Ngcobo N Clin Pharmacokinet. 2025; .

PMID: 39798015 DOI: 10.1007/s40262-024-01466-0.


Hip fracture rate and osteoporosis treatment in Ontario: A population-based retrospective cohort study.

AbuAlrob H, Ioannidis G, Jaglal S, Costa A, Grifith L, Thabane L Arch Osteoporos. 2024; 19(1):53.

PMID: 38918265 PMC: 11199290. DOI: 10.1007/s11657-024-01402-6.


Medication Dosage Impact on Mortality in Old-Age Individuals with Schizophrenia: A National Cohort Study.

Li J, Yeh L, Lin J, Pan Y Pharmaceuticals (Basel). 2024; 17(1).

PMID: 38256911 PMC: 10820447. DOI: 10.3390/ph17010078.